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Interactions of adult neural stem cells (NSCs) with
supportive vasculature appear critical for their main-
tenance and function, although the molecular details
are still under investigation. Neurotrophin (NT)-3 be-
longs to the NT family of trophic factors, best known
for their effects in promoting neuronal survival. Here
we show that NT-3 produced and secreted by endo-
thelial cells of brain and choroid plexus capillaries is
required for the quiescence and long-term mainte-
nance of NSCs in the mouse subependymal niche.
Uptake of NT-3 from irrigating vasculature and cere-
brospinal fluid (CSF) induces the rapid phosphoryla-
tion of endothelial nitric oxide (NO) synthase present
in the NSCs, leading to the production of NO, which
subsequently acts as a cytostatic factor. Our results
identify a novel interaction between stem cells and
vasculature/CSF compartments that is mediated by
an unprecedented role of a neurotrophin and indicate
that stem cells can regulate their own quiescence in
response to endothelium-secreted molecules.
INTRODUCTION
Neurotrophin-3 (NT-3; encoded by the Ntf3 gene) belongs to the
neurotrophin family of closely related neurotrophic factors,
which also includes nerve growth factor (NGF), brain-derived
neurotrophic factor (BDNF), and NT-4/5. Neurotrophins were
first identified as survival factors for developing neurons, but
they can also regulate cell fate decisions, axon and dendrite
growth, synaptic function and plasticity, or neuronal differentia-
tion during embryogenesis and in adulthood. Neurotrophins acti-
vate tyrosine kinase receptors of the tropomyosin-related kinase
(Trk) family, engaging different intracellular signaling pathways,
and can also interact with the p75 neurotrophin receptor, amem-572 Neuron 83, 572–585, August 6, 2014 ª2014 Elsevier Inc.ber of the tumor necrosis factor receptor superfamily (Reichardt,
2006). Although neurotrophin actions are characteristically
restricted to the nervous system, initial studies on the phenotype
ofNtf3mutant mice demonstrated that NT-3 was also implicated
in cardiac development (Donovan et al., 1996). Despite these
early findings outside the neural tissue, expression of NT-3 by
endothelial cells and its potential functions in the context of
vascular biology have begun to emerge only recently (Cristofaro
et al., 2010).
The murine subependymal zone (SEZ), adjacent to the lateral
ventricle ependymal wall, is a very active germinal niche in which
a continual process of progenitor cell replication and differentia-
tion results in the persistent production of olfactory bulb (OB) in-
terneurons and corpus callosum (CC) oligodendrocytes (Zhao
et al., 2008). The lifelong generation of these cells is supported
by radial glia-derived B1 cells, which express the astrocytic
antigen glial fibrillary acidic protein (GFAP) and stem cell markers
such as Nestin, Id1 and Sox2 and act as neural stem cells
(NSCs). Moreover, when activated, B1 cells divide slowly and
can hence retain bromodeoxyuridine (BrdU) for several weeks
(Nam and Benezra, 2009; Maslov et al., 2004; Pastrana et al.,
2009). B1 cells retain the elongated polarized morphology of
their radial glia predecessors and span between the ependyma,
which line the ventricle, and the network of blood vessels that irri-
gate the SEZ niche. Moreover, the thin apical process of B1 cells
intercalates among multiciliated ependymocytes and ends in a
single nonmotile primary cilium that can act as a sensor of
molecules present in the ventricular CSF (Falca˜o et al., 2012;Mir-
zadeh et al., 2008; Shen et al., 2008; Tavazoie et al., 2008). This
characteristic morphology correlates with experimental evi-
dence indicating that blood vessels and the CSF constitute regu-
lated sources of soluble signals acting on NSCs. However,
although some vasculature-derived signals have been shown
to activate NSCs (Calabrese et al., 2007; Ramı´rez-Castillejo
et al., 2006), the potential involvement of vascular signals in pro-
moting NSC quiescence and long-term maintenance is largely
unknown.
NT-3 is widely expressed during fetal development but its syn-
thesis becomes restricted to specific locations in the postnatal
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duced at high levels in the adult dentate gyrus (DG), where it
facilitates learning and memory by stimulating the differentiation
of neurons derived fromNSCs of the DG subgranular neurogenic
niche (Bath and Lee, 2010; Shimazu et al., 2006). However, the
potential role of NT-3 in the SEZ niche has not been investigated
so far. In this work, we show that NT-3 expressed and released
by endothelial cells of the brain vasculature supports quiescence
and long-term maintenance of B cells in the SEZ. Furthermore,
we demonstrate that B1 cells have access and respond to
NT-3 produced by endothelia and delivered by the CSF.
Mechanistically, NT-3 induces the rapid phosphorylation and
activation of an endothelial isoform of nitric oxide (NO) synthase
(eNOS) present in the NSCs themselves resulting in NO produc-
tion and NO-dependent cytostasis.
RESULTS
NT-3 Promotes NSC Quiescence and Long-Term
Maintenance
To evaluate the role of NT-3 in NSC behavior, and because Ntf3
null mice die immediately after birth, we analyzed the SEZ of 60-
day-old (60-d) heterozygous Ntf3+/lacZneo mice (CD1 genetic
background), which express reduced levels of the neurotrophin
(Figure S1A available online; Farin˜as et al., 1994, 1996). Although
we did not observe differences in the proportion of GFAP+ cells
(8.2 ± 0.6 versus awild-type value of 10.1 ± 1.1%; n = 5), reduced
amounts of NT-3 resulted in increased proportions of GFAP+
cells that were also positive for the cell cycle-specific antigen
Ki67 (17.0 ± 1.1% versus a wild-type value of 10.2 ± 0.7, n = 5;
two-tailed Student’s t test: p < 0.01). Analysis of cells exhibiting
Nestin or Sox2 in combination with GFAP in mice that had been
repeatedly injected with BrdU (seven times at 50 mg/kg of
body weight, one injection every 2 hours) during the 12 hr period
preceding euthanasia revealed a higher proliferative rate of
GFAP+, GFAP+Nestin+, and GFAP+Sox2+ cells in heterozygous
than in wild-type mice. Additionally, GFAP+ cells that were pos-
itive for the cell cycle antigen Ki67 exhibited higher BrdU incor-
poration rates in mutant animals, suggesting that NT-3 slows
down the cycling or delays the reentry into the cell cycle of acti-
vated B cells (Figures 1A–1D).
Consistent with more activated B cells, Ntf3 heterozygous
mice yielded more primary neurospheres than wild-types (Fig-
ure 1E andFigure S1B), although they did not differ in size (sphere
diameter in epidermal growth factor [EGF] + fibroblast growth
factor [FGF], in mm: 44.9 ± 3.1 in wild-types and 46.9 ± 1.8 in
Ntf3 heterozygous mice, n = 6 independent cultures per geno-
type). Importantly, no changes in B cell proliferation or in the yield
of primary neurospheres were found in postnatal 7-day-old
mutants (Figure 1E and Figures S1C–S1E). Together, the data
suggested that NT-3 plays a cytostatic role in the mature SEZ.
Higher numbers of neurospheres obtained from 60-day-old
heterozygous mice were followed by a decline in primary neuro-
sphere yield as the animals aged, starting at around 150 days
and reaching a reduction of around 70% of the wild-type values
by 240 days (Figure 1E), an indication that increased activity of B
cells could be leading to their exhaustion. Again, lower numbers
of neurospheres were not accompanied by changes in neuro-sphere diameter (40.1 ± 4.3 mm in wild-types and 40.0 ± 3.4 in
Ntf3 heterozygous mice, n = 6). Activated NSCs can be detected
in vivo based on their ability to retain nucleoside labels for more
than 2 weeks (Maslov et al., 2004) and, in agreement with higher
numbers of activated B cells, Ntf3+/lacZneo young mice also had
more cells that retained BrdU repeatedly injected 1month before
sacrifice (BrdU-labeling retaining cells or LRC), more GFAP+/
Sox2+ LRC, and more LRC that were also Ki67+ (Figures 1F–
1H). In contrast, we found significantly reduced proportions of
LRCs at 240 days in Ntf3 heterozygous mice (Figure 1H).
Because this could be the result of NSCs withdrawing from the
cell cycle and engaging terminal differentiation, we stained for
GFAP and S100b, a calcium-binding protein which is a marker
of late astrocytic development and loss of stem cell potential
(Raponi et al., 2007). We found increased proportions of
GFAP+ cells that were also S100b+ at 240 days relative to
60 days inNtf3 heterozygousmice (Figures 1H and 1I), indicating
that B cells proliferate more actively and prematurely differen-
tiate in animals with reduced levels of NT-3.
The temporal pattern of hyperactivity followed by exhaustion
of the B cell pool was accompanied by correlating changes
in neuro/oligodendrogenic output. Increased activity of the
GFAP+ population in youngNtf3 heterozygotes resulted in higher
numbers of Olig2+ newly generated oligodendrocytes (BrdU-
retaining cell progeny in the CC) and of newly generated neurons
(BrdU-retaining cell progeny in the OB glomerular layer: 120 ± 1
versus a wild-type value of 85 ± 4 cells/mm2; n = 4, p < 0.001;
Figures 2A and 2B), suggesting that NT-3 regulates the rate of
production of B cell derivatives without apparent effects on
fate choice. In the OB of Ntf3 heterozygotes versus wild-types,
we found increased generation of glutamate decarboxylase
(GAD67)+ (111 ± 18 versus 64 ± 14), tyrosine hydroxylase (TH)+
(36 ± 3 versus 25 ± 3), and GAD67+/TH+ (26 ± 3 versus 12 ± 2
cells/mm2; n = 4, p < 0.05) periglomerular interneurons (Figures
2B and 2C). Consistent with this increase, young Ntf3 heterozy-
gous mice exhibited functional deficits in olfactory behavior re-
flected in higher detection thresholds (Figure S1F) and reduced
discrimination of nonemotional odorants (Figure 2D), a result
that is compatible with previous observations that an excess of
inhibitory neurons results in olfactory discrimination deficits
(Mouret et al., 2009). However, at 240 days, both OB neurogen-
esis and oligodendrogenesis were significantly reduced in het-
erozygotes (Figure 2E). Together, these data indicate that the
cytostatic effect of NT-3 is required for the quiescence and
long-term maintenance of B cells and highlights the remarkable
dosage effect in the action of this neurotrophin (Farin˜as et al.,
1994).
NT-3 Is Produced and Released by Endothelial Cells and
Activates TrkC in NSCs
Analysis of b-galactosidase (b-gal) histochemistry in the fore-
brain of adult Ntf3+/lacZneo mice (Farin˜as et al., 1996) was consis-
tent with previous work (Vigers et al., 2000) and revealed high
levels of NT-3 expression in neurons and astrocytes of different
areas, including the olfactory cortex, septum, hippocampus, or
the nucleus of the stria terminalis (Figure S2A). In contrast, we
did not observe any obvious X-gal staining in the SEZ of
Ntf3+/lacZneo mice (Figure 3A). More in-depth analysis at highNeuron 83, 572–585, August 6, 2014 ª2014 Elsevier Inc. 573
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Figure 1. NT-3 Acts as a Quiescence and Maintenance Factor in the Adult SEZ
(A) Ki67, GFAP, and BrdU injected on the day of euthanasia in the SEZ of wild-type (Ntf3+/+) and heterozygous (Ntf3+/lacZneo)mice at 60 days (d, days after birth).
(B) Sox-2, GFAP, and BrdU.
(C) Nestin, GFAP, and BrdU.
(D) Histogram showing the percentage of BrdU+ cells among different cell subpopulations.
(E) Primary sphere yield from heterozygous relative to wild-type littermates (dashed line) at different ages.
(F) Sox-2, GFAP, and BrdU injected 1 month before euthanasia (LRC).
(G) Percentages of LRCs in the SEZ of wild-type and Ntf3+/lacZneo mice.
(H) Percentages of LRCs and GFAP+S100b+ cells at 60 days and 240 days.
(I) GFAP and S100b at 240 days. DAPI was used for counterstaining. White arrowheads indicate double or triple positive cells.
*p < 0.05; **p < 0.01; Scale bars represent 10 mm in (A–C), (F), and (I). Error bars represent mean ± SEM.
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Figure 2. NT-3 Modulates Neurogenesis to
the Glomerular Layer of the Olfactory Bulb
and Oligodendrogenesis to the Corpus
Callosum
(A) Olig2+ and BrdU+-label retaining cells (LRC) in
the corpus callosum (CC; left) and the olfactory
bulb-glomerular layer (OB-GL; right). DAPI was
used for nuclear staining. Scale bars represent
15 mm (left) and 30 mm (right).
(B) Olig2+ LRC in the CC and newborn neurons in
the OB-GL in 60-day-old mice.
(C) Newborn inhibitory OB-GL neurons (GAD67+
TH+ LRC). Scale bars represent 10 mm; also for
inset.
(D) Habituation-dishabituation test for odor stimuli
showing deficits in odor recognition and habitua-
tion in Ntf3+/lacZneo mice.
(E) Olig2+ LRC in the CC and newborn neurons in
the OB/GL at 240 days. White arrowheads indicate
double or triple positive cells.
*p < 0.05; **p < 0.01. Error bars represent
mean ± SEM.
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NT-3 and Neural Stem Cellsmagnification indicated, however, that CD31+ brain endothelial
cells contained levels of b-gal that could be detected by both
immunohistochemistry and X-gal histochemistry (Figures 3B
and 3C and Figure S2B). In line with the presence of b-gal in
blood vessels, we detected NT-3 with ELISA in cell lysates and
conditioned media of primary CD31+ endothelial cells (BECs)
acutely isolated from adult mouse brains (Andjelkovic et al.,
2003). We could also detect NT-3 protein in choroid plexus
(CP) homogenates and, more interestingly, in CSF directly iso-
lated from the cisterna magna of adult mice (Liu and Duff,
2008; Figures 3D and 3E).
NT-3, but not b-gal protein could be readily detected by immu-
nohistochemistry in ependymal cells lining the ventricle and in
GFAP+ B1 cells, both in sections and in SEZ whole-mounts in
which uniciliated B1 cells can be positively identified by double
immunostaining for basal cilia marker g-tubulin and GFAP (Fig-
ures 3C and 3F and Figures S2C–S2G). Because the antibodies
to NT-3 were specific, as tested inNtf3 null fetal brain tissue (Fig-
ures S3A and S3B), these data suggested that B1 cells do not
produce, but take up the neurotrophin and that vascular NT-3
could be acting as an endothelial niche and CSF regulator of
NSC behavior.
Subependymal GFAP+ cells had immunodetectable levels of
TrkC and TrkB, but not TrkA, and neurosphere cultures ex-
pressed TrkC, but not NT-3 (Figures 3G–3I and Figure S3C).
Treatment of neurospheres with human recombinant NT-3 for
5 min induced the phosphorylation of its cognate receptor
TrkC (Figure 3J). Moreover, exogenous addition of NT-3 to cul-
tures of isolated NSCs reduced neurosphere formation, without
affecting cell survival or neurosphere size (52.4 ± 3.1 mm versus
51.3 ± 2.8 in NT-3-treated cultures; n = 6), and the reduction was
rescued by addition of a blocking TrkC antibody (Figure 3K and
Figure S3D). Medium conditioned by BECs induced increased
formation of neurospheres as described previously (Shen et al.,2008), but addition of the TrkC antibody further increased the
yield (Figure S3E), indicating that NT-3 released by endothelial
cells inhibits proliferation through TrkC.
Endothelial NT-3 Regulates Quiescence of NSCs
To test whether brain endothelial NT-3 regulates NSC quies-
cence in vivo, we crossed mice carrying loxP sites flanking the
Ntf3 exon (Ntf3flox1/lox2; Shimazu et al., 2006), with mice express-
ing the Cre-recombinase under the control of the endothelium-
specific angiopoietin receptor tyrosine kinase receptor-2 (Tie2/
Tek) promoter (Tie2-cre+/0; Kisanuki et al., 2001). This resulted
in elimination of NT-3 in blood vessels of Ntf3flox1/lox2;Tie2-
cre+/0 (referred to as Ntf3-Tie2ko) compared to Ntf3flox1/lox2;
Tie2-cre0/0 (Ntf3-Tie2control) mice, with no changes in brain
vasculature overall growth or morphometry (Figures S4A–S4F).
In line with this, we could still detect NT-3 in brain areas with
neuronal expression such as the hippocampus, but not in
CD31+ cells or in BECs isolated from the deleted mice (Figures
S4G–S4I). Likewise, we could not detect NT-3 with ELISA in
CP homogenates and CSF directly obtained from Ntf3-Tie2ko
mice (Figure S4H), demonstrating that NT-3 produced and
released by endothelial cells in the CP is taken up by the choroid
epithelium through absorptive endocytosis and undergoes
transcytosis to be released into the CSF, as described for other
proteins (Balin and Broadwell, 1988; Strazielle and Ghersi-Egea,
2013). This together with the abrogation of NT-3 immunodetec-
tion in ependymal cells lining the ventricle and in subependymal
GFAP+ cells in Ntf3-Tie2ko mice (Figure S4J) further indicated
that endogenous NT-3 acting on B1 cells is provided by
endothelial cells, either directly from irrigating blood vessels or
via CSF.
Although the Tie2 promoter becomes activated during fetal
development and the lack of vascular NT-3 results in partial
embryonic lethality, as in Ntf3 nulls (Donovan et al., 1996;Neuron 83, 572–585, August 6, 2014 ª2014 Elsevier Inc. 575
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Figure 3. NT-3 Produced by Endothelial Cells Is Taken up by GFAP+ Subependymal Cells
(A) b-galactosidase (b-gal) histochemistry in the brain of Ntf3+/lacZneo mice. Insert shows a high-magnification image of the SEZ.
(B) Immunofluorescence for b-gal in CD31+ (upper) or GFAP+ (lower) cells in the SEZ ofNtf3+/lacZneomice. Arrowheads point at b-gal+ dots; open arrow points at a
GFAP+ cell.
(C) NT-3 protein in CD31+ blood vessels in the adult SEZ of wild-type mice. Arrowhead points at a doubly positive endothelial cell.
(D) NT-3 protein in cultured CD31+ brain endothelial cells (BECs) (upper); immunoblot for NT-3 in hippocampus (HPC) and BEC homogenates relative to b-actin
(lower).
(E) NT-3 detection by ELISA in different tissues (SEZ, CP, HPC), cell types (BECs, NSCs) and conditioned media (CM) and CSF.
(legend continued on next page)
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Figure 4. Endothelial NT-3 Regulates NSC
Proliferation
(A) BrdU, GFAP, and Ki67 in the SEZ of Ntf3-Tie2ko
and control mice. Arrowheads point at doubly
positive cells; open arrow points at a triple-positive
cell.
(B) Percentage of positive cells in Ntf3-Tie2ko and
control mice.
(C) CD31, GFAP, and Ki67 in SEZ whole mounts.
High magnifications are shown in the insets
(arrowheads point at GFAP+ cells).
(D) Primary spheres from Ntf3-Tie2ko and control
mice.
(E) Schematic drawing showing the NSC/BEC
coculture system (left). Number of neurospheres
formed in cocultures with wild-type BECs, treated
with anti-NT-3 or a nonrelated control antibody
(NRA), or Ntf3+/lacZneo BECs (right).
(F) Number of neurospheres formed in cocultures
with Ntf3-Tie2ko or control BECs, with and without
exogenous NT-3 or L-NAME. DAPI was used for
nuclear staining.
*p < 0.05; **p < 0.01; Scale bars represent 10 mm in
(A), (C), and (E); for inset in (C), 5 mm. Error bars
represent mean ± SEM.
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NT-3 and Neural Stem CellsFigure S4K), no changes in proliferation were observed in the
SEZ of surviving Ntf3-Tie2ko versus control mice at early
postnatal stages (Figure S4L). However, GFAP+ cells of the
mature SEZ were proliferating more actively in Ntf3-Tie2ko(F) NT-3 and GFAP in the adult SEZ. Arrowhead points at a doubly positive cell.
(G) Quantitation of Ntf3 and TrkC relative to Gapdh mRNAs.
(H) TrkC in neurospheres.
(I) TrkC and GFAP in the SEZ. Arrowheads point at doubly positive cells.
(J) Protein extracts from NT-3-treated NSCs immunoprecipitated (IP) with anti-phospho-tyrosine (pTyr) and
and anti-pTyr. Immunoblot for pTrkC and TrkC in lysates from NT-3-treated NSCs.
(K) Numbers of neurospheres formed in the presence or not of NT-3 in combination with TrkC or nonrelevant
used for nuclear staining.
*p < 0.05; **p < 0.01; V, ventricle; Str, striatum; Sp, septum; cc, corpus callosum; Cx, cortex. Scale bars repre
(F), and (I); and 5 mm in (H). Error bars represent mean ± SEM.
Neuron 83, 572–5mice (Figures 4A and 4B), as they were in
Ntf3 heterozygous mice, and apparently
had more Ki67+/GFAP+ B1 cells next to
vascular elements (Figure 4C). Primary
sphere yield was also significantly higher
when cells were dissociated from the
SEZ of 60-day-old Ntf3-Tie2ko versus
control mice (Figure 4D). These data
together indicated a functional effect of
endothelial NT-3 in NSC proliferation.
To further demonstrate the functional
effects of NT-3, we established indirect
cocultures of NSCs with different NT-3-
expressing endothelia, such as venous
endothelial cells derived from human um-
bilical cords (hUVECs), as well as primary
BECs and aortic rings (AR) isolated from
our mice (Figures S5A–S5E). AR were
cultured as previously described (Aplinet al., 2008); a dense rich layer of different cell types migrated
outward from the ring, including CD31+ endothelial cells that
took up fluorescent acetylated low-density lipoprotein (Dil-Ac-
LDL) and formed tubular vessel structures (Figure S5B).immunoblotted (IB) for anti-phospho-TrkC (pTrkC)
(NRA) antibodies. DAPI (blue) or Sytox (green) were
sent 150 mm in (A; inset in A, 10 mm); 10 mm in (B–D),
85, August 6, 2014 ª2014 Elsevier Inc. 577
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NT-3 and Neural Stem CellsSupporting our in vivo results, we found higher numbers of neu-
rospheres in cocultures of NSCs with wild-type BECs and AR or
with hUVECs if NT-3 blocking antibodies were added to the co-
cultures (Figure 4E and Figures S5F and S5G). Additionally, wild-
type NSCs formed more neurospheres when cocultured with
BECs from Ntf3+/lacZneo mice or with BECs or AR from Ntf3-
Tie2ko mice relative to wild-type BECs or AR, an increase that
could be eliminated by the exogenous addition of NT-3 (Figures
4E and 4F and Figure S5H). These data identified endothelia as a
natural source of NT-3 controlling NSC cycling.
Cytostatic Effects of Endothelial NT-3 Are Mediated by
Increased NO Production in NSCs
We next investigated the mechanism underlying this unprece-
dented role of NT-3 in NSC quiescence. NO is synthesized by
the enzyme NOS that catalyzes the conversion of L-arginine
and oxygen into citrulline and second messenger NO. Three
different NOS isoforms have been identified in mammals: consti-
tutive neuronal NOS (nNOS; encoded by the Nos1 gene) and
endothelial NOS (eNOS; Nos3), and inducible NOS (iNOS;
Nos2; Fukumura et al., 2006). NT-3 reportedly modulates the
level and/or activity of eNOS in rat brain and pulmonary vascula-
ture (Meuchel et al., 2011; Takeo et al., 2003). To analyze
whether production of NO could be mediating the effects of
NT-3 on NSCs, we first used a pharmacological approach with
constitutive NOS competitive inhibitor L-NAME (Rees et al.,
1990) and nNOS specific inhibitor SMTC (Furfine et al., 1994).
Treatment with L-NAME increased neurosphere formation in
cocultures of NSCs with AR and rescued the reduction caused
by addition of exogenous NT-3; in contrast, SMTC had no effects
in either the presence or the absence of exogenously added
NT-3, suggesting that nNOSwas not involved (Figure S6A). Like-
wise, treatment with L-NAME increased neurosphere formation
in coculture experiments with BECs isolated from control, but
not Ntf3-Tie2ko mice (Figure 4F), suggesting a model in which
NO produced by eNOS in response to vascular NT-3 regulates
quiescence in the perivascular niche.
We next used a genetic approach by performing cocultures
with NSCs and BECs isolated from adult Nos3 mutant and
wild-type mice (Huang et al., 1995). Neurosphere formation by
wild-type NSCs was similar, independently of the BECs geno-
type; more intriguingly, neurosphere formation was increasedFigure 5. Endothelial NT-3 Induces eNOS Activity in NSCs
(A) Schematic drawing showing the NSC/BEC coculture system (left). Number of n
BECs, in the absence or in the presence of L-NAME (middle) or by Nos3+/+ or N
(B) GFAP and eNOS in sections. Open arrows point at an eNOS-negative striatal a
point at eNOS+ subependymal GFAP+ cells.
(C) GFAP and nNOS in the SEZ. Open arrows point at nNOS+/GFAP-negative ce
(D) Levels of phosphorylated eNOS (p-eNOS) in neurospheres after treatment w
p-eNOS in SEZ homogenates of wild-type and Ntf3+/lacZneo mice.
(E) DAF-2 fluorescence in neurospheres at different times after NT-3 stimulation.
(F) Quantitation of DAF-2 fluorescence (arbitrary units, a.u.) after treatment with
fluorescence was used as a control (blue line).
(G) Quantitation of DAF-2 fluorescence intensity after treatment with CM of BEC
(H) Numbers of neurospheres formed by NSCs from a C57BL/6 strain (left bars)
mutant strain (right bars), in the absence or in the presence of NT-3 alone or in c
(I) Levels of pTrkC and TrkC in lysates from NT-3-treated Nos3+/+ or Nos3/ NS
*p < 0.05; **p < 0.01; Scale bars represent 10 mm in (A–C) and (E). Error bars repin both conditions following treatment with L-NAME, suggesting
that the observations were not the result of eNOS inhibition in
endothelial cells. Notably, in the complementary experiments
with Nos3 wild-type and mutant NSCs in coculture with wild-
type BECs, more neurospheres were produced by eNOS-
deficient NSCs, even in the absence of L-NAME (Figure 5A).
Together, these data suggested the possibility that NSCs con-
tained an endothelial form of NOS that was relevant for the
observed phenotype in vitro. Indeed, the expression profile for
NOS isoforms in NSCs was similar to that of endothelial cells
and we found detectable levels of mRNA and protein for
eNOS, but not nNOS in cultured NSCs (Figure S6B). Moreover,
eNOS could be readily immunodetected in SEZ GFAP+ cells
and irrigating capillaries, whereas nNOS immunoreactivity was
confined to neurons (Figures 5B and 5C and Figures S6C–
S6E). Remarkably, GFAP+ mature astrocytes within the adjacent
striatal parenchyma (Figure 5B) or other brain areas (not shown)
did not contain immunodetectable levels of eNOS. The data indi-
cated that the predominant NOS enzyme in SEZ neurogenic
astrocytes is the endothelial isoform.
Because NSCs expressed eNOS, we next determined
whether NT-3 could regulate NO production in these cells. Treat-
ment with NT-3 significantly increased the level of eNOS phos-
phorylation in both aorta and neurosphere cultures (Figure 5D
and Figure S6F) and eNOS phosphorylation was reduced in
SEZ homogenates of Ntf3 heterozygous mice (Figure 5D).
Furthermore, neurospheres cultured in medium conditioned by
Ntf3-Tie2ko BECs showed lower levels of phosphorylated
eNOS (Figure 5D). Direct monitoring of NO production with the
specific fluorescent probe DAF-2 (Zhou and He, 2011) indicated
increased production in neurospheres treated with NT-3 or
cultured in BEC-derived conditionedmedia, and the signal could
be reduced by treatment with L-NAME (Figures 5E–5G and Fig-
ures S6G and S6H). To test the potential role of NO produced by
NSCs themselves, we cultured isolated NSCs in the presence of
exogenously added NT-3 and/or L-NAME. Indeed, the NOS in-
hibitor rescued the deficit in neurosphere formation induced by
NT-3 (Figure 5H). Moreover, although treatment with NT-3
induced the phosphorylation of the receptor TrkC to similar
levels in Nos3 wild-type and mutant NSC cultures, the number
of neurospheres formed in the presence of the neurotrophin
was reduced in the wild-type, but not in the mutant cultureseurospheres formed bywild-type NSCs in cocultures with wild-type orNos3/
os3/ NSCs in cocultures with wild-type BECs (right).
strocyte; open arrowheads point at eNOS+ blood vessel, and solid arrowheads
lls.
ith NT-3 or with medium conditioned (CM) by Ntf3-Tie2ko or control BECs.
Hoechst was used for nuclear staining.
NT-3 alone (green line) or in combination with L-NAME (purple line). Hoechst
s from Ntf3-Tie2ko and control mice.
or by wild-type and homozygous NSCs from the mixed C57BL/6.Sv129 Nos3
ombination with L-NAME. DAPI was used for counterstaining.
Cs.
resent mean ± SEM.
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Figure 6. NT-3 from the CSF Supports
Quiescence of B1 Cells
(A) Dot-blot detection of biotinylated NT-3 (NT-3b;
upper) and scheme of the intracerebro-ventricular
injection of NT-3b.
(B) NT-3b detection with TRITC-streptavidin in
sections of noninfusedmice as a control. DAPI was
used for counterstaining.
(C) NT-3b, S100b, and GFAP in NT-3b injected
mice. Insets show high-magnification images.
(D) Schematic depicting the intracerebro-ventric-
ular infusion of NT-3 using osmotic minipumps.
(E) Percentages of GFAP+ cells and of GFAP+ cells
that are also BrdU+ cells in infusedNtf3-Tie2ko and
control mice.
(F) Percentages of GFAP+ cells and of GFAP+ cells
that are also BrdU+ cells in infused Nos3/ and
control mice.
(G) GFAP and BrdU in Nos3/ and control mice.
*p < 0.05; Scale bars represent 10 mm in (B), (C),
and (G). Error bars represent mean ± SEM.
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NT-3 and Neural Stem Cells(Figures 5H and 5I). Our data suggested that increased eNOS
activity in NSCs themselves could account for NT-3 cytostatic
effects.580 Neuron 83, 572–585, August 6, 2014 ª2014 Elsevier Inc.CSF-Distributed NT-3 Instructs
Quiescence in Adult NSCs through
eNOS Activation
Our results indicated the presence of high
quantities of endothelia-derived NT-3 in
the CSF and, therefore, B1 cells could
be exposed to NT-3 released by adjacent
endothelial cells or present in the lateral
ventricle. It has been proposed that B1
cells can access molecules present in
the CSF through receptors present at the
membrane of their primary cilium (Falca˜o
et al., 2012). To test whether B1 cells
could indeed take up NT-3 from the
CSF, and because reliable assessment
of the presence of specific receptors at
the primary cilium membrane is techni-
cally difficult, we biotinylated human
recombinant NT-3 which was then stereo-
taxically injected (as a single dose of
100 ng) into the lateral ventricle and
later detected with fluorescent streptavi-
din in sections of mice perfused 30 min
or 3 hr after the injection (Figure 6A).
Compared to control mice injected with
nonbiotinylated NT-3, which did not
reveal any fluorescent signal (Figure 6B),
we could detect the labeled neurotrophin
in the SEZ. The signal was restricted to
the first few 10–20 mm from the ventricle
lumen after either 30 min or 3 hr. More-
over, the signal was discrete and virtually
always colocalized with the immunode-
tection of S100b in the cytoplasm ofcells immediately adjacent to the lumen and with GFAP in sube-
pendymal cells. Remarkably, cells containing biotinylated NT-3
that were most distant to the ventricle were always GFAP+
Neuron
NT-3 and Neural Stem Cells(Figure 6C and Figure S7A). These data indicated that B1 cells
have access to CSF-delivered NT-3 and suggested that this ac-
cessmight be due to receptor-mediated transport rather than in-
traparenchymal passive diffusion.
To functionally address the relevance of the CSF compart-
ment, we next evaluated whether B1 cells can respond to
CSF-borne NT-3 in the absence of direct endothelial sources
by infusing the neurotrophin into the lateral ventricles of Ntf3-
Tie2ko mice during 7 days, at a rate of 100 ng/day. Infusion in
mice lacking endothelial NT-3 did not change the size of the
GFAP+ population of subependymal cells, but reduced their
BrdU-incorporation rate to wild-type values (Figures 6D and
6E). Together, these results indicated that B cells can take
up NT-3, most likely through receptors present in their cilia,
and that this NT-3 can regulate their cycling/quiescence in a
direct way.
Our in vitro data indicated that the NT-3 effects on quiescence
were mediated by activation of the eNOS enzyme leading to NO
production in NSCs themselves. We, therefore, decided to test
the implication of the eNOS isoform present in B1 cells in
response to intraventricular NT-3. The SEZ phenotype of Nos3
mutant mice has been reported following experimental stroke,
but not under normal conditions (Chen et al., 2005). Despite
no significant changes in blood vessel morphometrical parame-
ters such as tube diameter or length, we found that the SEZ of
60-day and 240-day mutant mice was less irrigated than that
of wild-types under normal conditions, but we could obtain
yields of primary neurospheres similar to those from wild-type
SEZs (Figures S7B–S7F). Therefore, we decided to infuse
NT-3 or saline into the lateral ventricle of Nos3 wild-type and
mutant 60-day mice. We did not find differences in the number
of GFAP+ cells or in their proliferation rate in vehicle-infused
Nos3 mutant mice compared wild-type littermates (Figures 6F
and 6G). We did, however, decrease the proliferation of B1
GFAP+ cells in the wild-type but not in the eNOS-deficient
mice when NT-3 was infused (Figures 6F and 6G), an indication
that eNOS present in B1 cells could be mediating NT-3 actions
on quiescence also in vivo. Interestingly, and despite a lack of
apparent effects of the Nos3 targeted mutation on B cells in
young animals, 240-day eNOS-deficient mice exhibited reduced
numbers of subependymal BrdU-LRC in general and within the
population of GFAP+ and GFAP+Sox2+ cells (Figure S7G), sug-
gesting that eNOS is also required for the maintenance of NSCs
in the SEZ.
DISCUSSION
Recent studies have highlighted that SEZ stem cells and
derived progeny are intimately associated with blood vessels
and that subependymal B1 cells can access proteins in the
CSF through specific receptors present at their primary cilium
membrane (Falca˜o et al., 2012; Hjelmeland et al., 2011; Shen
et al., 2008; Tavazoie et al., 2008). However, direct or CSF-
delivered vascular signals involved in supporting quiescence
and long-term maintenance of NSCs had not been identified.
Our data support a model in which B1 cell quiescence can
be modulated by NO production in an autocrine manner in
response to NT-3 produced only by endothelia. NT-3 is inSEZ irrigating blood vessels and ventricular CSF, and B1 cells
have regulated access to both compartments. Moreover, prolif-
erative activity of B1 cells appears to be related to the level of
NT-3 available. Reductions of NT-3 lead to increased B1 cell
cycling, whereas experimental addition of NT-3 to the CSF re-
duces proliferation, suggesting that this signal plays an active
role in instructing quiescence in a dose-dependent manner.
These results provide novel insights into the interaction of adult
NSCs with their niche, and describe a mechanism of NSC
cycling regulation that requires a directional signaling from
endothelial sources.
Quiescence control has important implications in the mainte-
nance of adult stem cells. Genetic lineage tracing studies
have indicated that division-coupled terminal differentiation of
normal NSCs to a nonmultipotent mature astrocyte unavoidably
leads to a reduction of the stem cell pool in the DG sub-
granular zone (Encinas et al., 2011). Moreover, mutations that
disrupt quiescence and drive adult stem cells into active
constitutive proliferation, such as mutations in genes coding
for p21, result in stem cell hyperproliferation followed by loss
of stem cell potential and depletion of pluripotent stem cell
pools (see Porlan et al., 2013). Sustained reductions in the
levels of NT-3 leads to exhaustion of the potential to produce
neurospheres and GFAP+ cells appear to differentiate into
mature S100b+ astrocytes. CSF is a complex and dynamic fluid
with an important role in the distribution of signaling molecules
to the brain and the CP barrier can actively regulate the avail-
ability of somatic sources of CSF-distributed soluble cues to
brain cells, including B1 cells (Strazielle and Ghersi-Egea,
2013). It will be interesting to determine how this barrier con-
trols the availability of NT-3 to B1 cells under different condi-
tions, including aging.
The effects of neurotrophins in adult neurogenesis have been
investigated in recent years. Despite a relatively high number of
works analyzing the effects of BDNF and its signaling receptor
TrkB in the dynamics of the postnatal and adult SEZ, their poten-
tial effects are still unclear.Mostdata appear to support, however,
an action of BDNF in the survival of neuroblasts (reviewed in Bath
and Lee, 2010). As for NT-3, it has only been shown that loss of
NT-3 negatively affects the survival and proliferation of SEZ-
derived oligodendrocytes and promotes differentiation of DG
newly generated neurons (Kahn et al., 1999; Shimazu et al.,
2006). This is thefirst studyshowing thatNT-3,or anyotherneuro-
trophin, influencesB1cellmaintenance through actionsonquies-
cence. Interestingly, our findings indicate that the molecular
mechanism underlying NT-3 cytostatic effect on adult NSCs im-
plicates the production of NO through fast modulation of eNOS,
but not nNOS in the NSCs themselves. Fetal and early postnatal
NSCs had been shown to express eNOS (Li et al., 2006; Wang
et al., 1999). However, NT-3 effects appear restricted to the
mature SEZ and the lack of phenotype in the SEZ at early post-
natal ages that we describe here fully agrees with previously re-
ported data indicating that NT-3 is dispensable for OB neurogen-
esis during embryogenesis (Nef et al., 2001).
NO regulates many physiological processes through the NO/
cGMP pathway, as well as through protein S-nitrosylation (Fuku-
mura et al., 2006). NO can induce growth arrest in neural progen-
itors, promoting their differentiation (Cheng et al., 2003; PeunovaNeuron 83, 572–585, August 6, 2014 ª2014 Elsevier Inc. 581
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Figure 7. Proposed Mechanistic Model
NT-3 is produced and released by endothelial cells, and B1 cells take up the
neurotrophin directly from the irrigating vasculature or from the CSF. TrkC
activation by NT-3 leads to fast induction of eNOS activity in B1 cells through
phosphorylation and the produced NO reduces the cycling of the NSCs.
Production of NT-3 by vascular sources creates a specific requirement for
NSCs to proliferate in perivascular/periventricular niches.
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NT-3 and Neural Stem Cellsand Enikolopov, 1995). In the adult brain, a dual role of this sec-
ond messenger, either promoting or inhibiting proliferation of
neuronal precursors, has been reported. NO produced by nitrer-
gic neurons suppresses adult neurogenesis under physiological
conditions. NO inhibition augments neurogenesis in adult
germinal areas by promoting cell division without affecting pro-
grammed cell death, and the same effect is observed when
nNOS is inactivated, albeit it had not been determined yet
whether NO signaling participates in the maintenance of NSC
quiescence (Cheng et al., 2003; Moreno-Lo´pez et al., 2004;
Packer et al., 2003). Interestingly, it has been shown that consti-
tutive NOS blockade by L-NAME increases proliferation to a
much larger extent than inactivating mutations of nNOS (Cheng
et al., 2003; Moreno-Lo´pez et al., 2004; Packer et al., 2003), an
observation fully consistent with our reported implication of
eNOS in the regulation of subependymal NSCcycling. In contrast
to NO inhibitory effects during physiological conditions, vascula-
ture-derived NO can promote neuronal production during
ischemic insults (Cheng et al., 2003; Hjelmeland et al., 2011;Mor-
eno-Lo´pez et al., 2004; Packer et al., 2003; Zhang et al., 2001;
Zhu et al., 2003). In addition, brain tumor stem-like cells are often
found in close contact with tumor vascular endothelia expressing
elevated levels of eNOS (Calabrese et al., 2007; Iwata et al.,
1999). Indeed, it has been recently shown that NO promotes
Notch signaling in PDGF-induced glioma cells, increases their
capacity to produce neurospheres, and enhances their tumori-
genic capacity in vivo (Charles et al., 2010). All these data reveal
a complex scenario where production of NO may condition the582 Neuron 83, 572–585, August 6, 2014 ª2014 Elsevier Inc.stem cell niche in different ways. In this context, our data indicate
specific effects of NO, possibly in a cell-autonomous manner, in
the quiescence and maintenance of adult NSCs.
NSCs reside and proliferate in vascularized niches. Moreover,
they exhibit a characteristic morphology that allows them to be
exposed to signals derived from endothelia of the irrigating
vascular network and to signals present in the CSF. NSCs
appear endowed with the capacity to produce NO by activation
of an eNOS and the resulting NO can act as a cytostatic signal.
However, the activation of NO production requires the presence
of NT-3, which is not produced, but taken up by NSCs (Figure 7).
It is likely that the production of NT-3 by vascular sources creates
a specific requirement for NSCs to proliferate in perivascular/
periventricular niches.
EXPERIMENTAL PROCEDURES
Animals and In Vivo Manipulations
Ntf3flox1/lox2 (B6.129S4-Ntf3tm2Jae/J), Tie2-cre+/0 (B6.Cg-Tg(Tek-cre)1Ywa/J),
and Nos3 (B6. 129P2-Nos3tm1Unc/J) mice were obtained from The Jackson
Laboratory and genotyped as described (Huang et al., 1995; Kisanuki et al.,
2001;Shimazuet al., 2006).Housingandexperimentswerecarriedout following
protocols approved by the ethics committee of the Universidad de Valencia.
Mice were injected intraperitoneally with 50 mg/kg of BrdU every 2 hr for
12 consecutive hours (seven injections in total) and killed 1 hr or 30 days after
the last injection. Ten micrograms of recombinant human NT-3 (PeproTech)
was biotinylated using EZ-LinK Sulfo-NHS-Biotinylation (Thermo Scientific),
following instructions of themanufacturer, and buffer exchangewas performed
with Zeba Spin Desalting Columns, 7K MWCO (Thermo Scientific). Efficient
biotinylation was tested by dot-blot with peroxidase-conjugated neutrAvidin
(Molecular Probes). For delivery, mice were anesthetized and fixed to a
stereotaxic device (NeuroLab) and 1 ml NT-3b (100 ng/ml) was injected into the
lateral ventricle of the mice with a Hamilton syringe. Mice were perfused
30min or 3 hr after the injections and processed for detectionwith tetramethylr-
hodamine-conjugated neutrAvidin (Molecular Probes) in vibratome sections.
For infusions, infusion kit 3 cannulas attached to osmotic mini-pumps (Alzet,
model 1007D; flow rate 0.5 ml/h; Ferron et al., 2007) and loaded with recombi-
nant human NT-3 (8.4 ng/ml; 100 ng/day) or saline were inserted into one lateral
ventricle. Stereotaxic coordinates for intraventricular injections/infusions were
(millimeters from the bregma): anterior-posterior, 0.3; mediolateral, 0.8;
and dorsoventral, 3 from the skull surface.
Behavioral Tests
For threshold detection, mice were placed in a 22.53 22.5 cm open Plexiglas
box with solid light green walls and approximately 1 cm of wooden chip
bedding. After 3 min of free exploration, a cotton stick soaked in mineral oil
was introduced into the box through a 1-cm hole located 8 cm above the floor
and 11.2 cm from the corner. The stick was held in place for 1 min and there-
after substituted by a series of five consecutive fresh cotton sticks soaked also
in nonodorant mineral oil to produce habituation to the novel object. Mice were
then exposed to successive cotton sticks with increasing concentrations of
citralva (3,7-dimethyl-2,6-octadiene-1-nitrile; Vento´s SA; from 1:160 to 1:10)
diluted in mineral oil. For the habituation-dishabituation test, the six trials
with mineral oil were followed by six trials of geraniol (terpene geraniol; Vento´s
SA, Barcelona) and six trials of citralva, at 1:20. We used a digital video system
to record the olfactory exploration, including smelling, sniffing, heading toward
the cotton stick, approach (2–3 cm) or contact, and tracking evaluation
software (Smart Junior, Panlab S.L., Harvard Apparatus). After each test, the
olfactory exploration box was thoroughly wiped clean with 5% alcohol and
dried.
Immunohistochemistry and b-Galactosidase Histochemistry
Embryos were fixed by immersion in 4% paraformaldehyde (PFA) in 0.1 M
phosphate buffer pH 7.4 (PB) for 4 hr and mice were first deeply anesthetized
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sectioned with a vibratome (Leica VT1000) at 25 mm. Sections were incubated
in 10% fetal bovine serum (FBS) and 0.1%Triton X-100 in PB for 1 hr, and over-
night in primary antibodies (Table S1A). For BrdU detection, sections were first
incubated in 2M HCl for 20 min at 37C and neutralized in 0.1M sodium borate
(pH 8.5). Detections were performed with fluorescent secondary antibodies
(Table S1B). Biotinylated IB4 lectin (1:100; Sigma) was detected with Cy3-
conjugated streptavidin (1:300; Jackson Immuno-Research Laboratories).
For SEZ whole mounts, we used protocols established previously (Mirzadeh
et al., 2008). Briefly, the lateral ventricle walls were dissected out and fixed
for 1.5 hr in 4% PFA in PB and washed overnight at 4C in PB. Whole mounts
were washed three times in PB containing 2% Triton X-100 for 15 min each,
blocked for 2 hr in 10% FBS and 2% Triton X-100 in PB, then incubated
with primary and secondary antibodies in the same blocking solution for
48 hr each at 4C. Fluorescent samples were mounted with Fluorsave
(Calbiochem), and 40,6-diamidino-2-phenylindole (DAPI; 1 mg/ml, 5 min) or
Sytox Green (1:1,000; Molecular Probes) were used for counterstaining. Sam-
ples were analyzed with Leica Microsystems Multispectral and Olympus FV10
confocal microscopes. To score numbers of cells in the SEZ we analyzed
series of five 25-mm-thick vibratome sections 600 mm apart at AP coordinates
1.10, 0.86, 0.62, 0.38, and 0.14, covering the extent of the SEZ between 1.70
and 0.02. Confocal microscopy images were taken at 1003 magnification.
Every region of interest had a z stack of 20 mm, with optical sections every
1 mm. Quantifications were made in three different levels of every z stack
ensuring no double counting. OB counts were done in series containing six
or seven sections 300 mmapart between AP coordinates 4.5 and 3.5. Confocal
images of the entire glomerular layer were obtained at 603 magnification in
every section. At least 17 fields were analyzed in each slice and the glomerular
area was measured to determine density. For X-gal histochemistry, brains
were fixed by immersion in 4% PFA in PBS at pH 7.4 with 2 mM MgSO4
and 5 mM EGTA for 30 min at 4C and processed for vibratome sectioning.
Sections were incubated in PBS with 2 mM MgCl2, 5 mM K3Fe(CN)6, 5 mM
K4Fe(CN)6, 0.01% sodium deoxycholate, 0.02% NP-40, and 1 mg/ml X-Gal
for 24 hr and counterstained with nuclear fast red.
Cell and Organotypic Cultures
Methods for NSC culture, neurosphere formation analysis, viability measure-
ments, and BrdU immunocytochemistry have been described (Ferron et al.,
2007). Primary spheres were counted and their diameters measured after
5 days in vitro and established neurosphere cultures were always analyzed
at passage 5. For passages, neurospheres were treated with Accutase
(0.5 mM; Sigma) for 10 min, mechanically dissociated to a single-cell suspen-
sion, and replated in growth medium containing EGF and fibroblast growth
factor, supplemented or not with human recombinant NT-3 (20 ng/ml;
PeproTech). NOS pan-inhibitor NG-nitro-L-arginine methyl ester (L-NAME,
Sigma; Rees et al., 1990) or the inhibitor nNOS S-methyl-L-thiocitrulline
(SMTC, Sigma; Furfine et al., 1994) were used at 100 mM and 1 mM, respec-
tively. Blocking rabbit IgGs to NT-3, to TrkC and nonrelevant IgGs (Santa
Cruz Biotechnology) were used at 3 mg/ml. hUVEC and media were from
AdvanCell. BECs were obtained as previously described (Andjelkovic et al.,
2003) with modifications. Briefly, brains from 60-day-old mice were minced
in Hanks balanced salt (HBSS; Invitrogen) and homogenized gently with a
21G needle syringe. The microvessels were cleaned from myelin using an
18% dextran solution (in MEM with HEPES and A/A; GIBCO) and separated
from erythrocytes by centrifugation at 9, 0003 g for 10 min. The microvessels
were digested in HBSS containing 1 mg/ml collagenase/dispase (Roche) for
1 hr at 37C. BECs were plated on rat-tail extracted collagen and cultured in
endothelial cell growth medium MV2 (Ready-to-use; Promocell). Aortas were
dissected free of periaortic fibro-adipose tissue and sectioned transversally
into 1-mm rings, which were embedded in Matrigel matrices (BD Bioscience)
and cultured in MV2 (Aplin et al., 2008). AR cultures were incubated at 37C for
5 days with 1,1-dioctadecyl-3,3,3,3-tetramethyl-indocarbocyanine-labeled
acetylated low-density lipoprotein (DiI-Ac-LDL; Molecular Probes) at 5 mg/ml
and then fixed with 4% PFA for 20 min. The medium was replaced every
48 hr and the vessels were allowed to form for 5 days. For coculture experi-
ments, MV2 medium was replaced by neurosphere growth medium, a
transwell insert (0.4-mmpore, Millipore) was placed above after 2 hr, and disso-ciated neurosphere cells were seeded in the upper compartment at a 2.5
cell/ml density. Neurosphere formation was analyzed after 5 days.
NO Production Assay
The NO-sensitive membrane-permeable fluorescein-based chromophore dia-
minofluorescein diacetate (DAF-2 DA; Calbiochem) reacts with NO to form a
benzotriazole product, which emits in the fluorescein emission range and
can be used to monitor the production of NO in living cells (Zhou and He,
2011). Neurospheres and whole aortas/AR were seeded on Matrigel, loaded
with 10 mM of DAF-2 and kept at 37C for 45 min. Fluorescence images
were captured at different time points using an Olympus FV10 confocal micro-
scope. At least 50 spheres were analyzed for each condition in neurosphere
cultures. NO was measured in portions comprising the entire width of the
vessel, from the adventitia to the endothelium. Because the vessel wall ex-
hibited the characteristic basal fluorescence of elastin fibers, this was de-
ducted from the quantification. Hoechst fluorescence was used as a control.
Quantification of fluorescence intensities was performed using the software
Microimage from Olympus.
Immunoblot, Immunoprecipitation, and ELISA
Cells and tissues were lysed in sodium dodecyl sulfate (SDS)-buffer (25 mM
Tris-HCl, pH 7.4, 1 mM EDTA, 1% SDS), supplemented with phosphatase
and protease inhibitors. Approximately 30 mg of protein extract was resolved
with SDS-PAGE. For immunoprecipitations, 107 cells were split in two and
treated or not with 20 ng/ml NT-3 for 10 min, collected on ice in PBS supple-
mented with sodium orthovanadate, and lysed in 25 mM Tris-HCl, pH 7.4,
150 mMNaCl, Triton X-100 1% and 1 mM EDTA supplemented with phospha-
tase and protease inhibitors. Lysates were incubated overnight with 3 mg of
anti-pTyr antibody (clone 4160; 1:500; Millipore) and Dynabeads protein G
(Invitrogen) was used to retrieve the immunoprecipitates. Beads were incu-
bated with Laemmli buffer and separated from the samples using a magnet.
Immunoprecipitates were resolved in 4%–15% Criterion TGX Precast Gel
(Bio-Rad) and transferred to nitrocellulose membranes (Protran Sigma). Mem-
branes were blotted with primary (Table S1) and secondary peroxidase-
conjugated antibodies (1:5,000; Dako) and reacted by chemiluminiscence
(Western Lighting Perkin Elmer). Membranes were stripped off the first
antibodies using 200 mM glycine pH 2.5, 0.02% SDS, and reblotted as
specified. Films were scanned and band density quantitatedwith Image J soft-
ware. NT-3 protein levels were measured with ELISA using the NT-3 Emax
Immunoassay System Kit specific for mouse NT-3 (Promega) according to
the manufacturer’s protocol. For measurements in serum-free conditioned
media and cell lysates, BECs were grown for 2 days and CPs were acutely iso-
lated. Cell/tissue samples were lysed with 20 mM Tris-HCl pH 8.0, 137 mM
NaCl, 1% NP40, 10% glycerol, 1 mM PMSF, 10 mg/ml aprotinin, 1 mg/ml leu-
peptin, and 0.5 mM sodium vanadate, and total protein concentration was
determined using a BCA Kit (Pierce). CSF was collected using a glass capillary
tube with an inner diameter of 0.5 mm through a puncture in the cisterna
magna of adult mice, as previously described (Liu and Duff, 2008). Serial
dilutions of recombinant mouse NT-3 were used to calibrate the assay and
ensure that experimental samples were within the linear range of detection.
Resultant measurements of NT-3 (pg/ml) were normalized to total milligrams
of protein.
RNA Isolation and Expression Analysis
RNAs were extracted with RNeasy MicroKit (QIAGEN) and 1 mg of RNA was
reverse-transcribed into cDNA using random primers and SuperScript II RT
reverse transcriptase (Invitrogen) in the presence of first strand buffer
(50 mM Tris-HCl, 75 mM KCl, 3 mM MgCl2), 5 mM dithiothreito, and
0.25 mM each of dNTPs (Amersham) for 2 hr at 42C. One microliter of the
reverse-transcribed RNA was amplified by PCR with appropriate primers
(Table S2A). Quantitative PCR was performed by real-time PCR in a DNA
Engine 2 Opticon detection system (Bio-Rad) using SYBR green I as a
double-strand DNA-specific binding dye. Thermocycling was performed in a
final volume of 20 ml containing 2 ml of cDNA sample (diluted 1:5), 20 pmol of
each primer (Table S2A), 2 mMMgCl2, 0.2 mM dNTP mixture, 1X Taq reaction
buffer, 0.5 U HotStart Taq DNA polymerase, and 0.5 ml of a 1:3,000 dilution of
SYBER green I. For Ntf3 and Gapdh (as endogenous control) detection,Neuron 83, 572–585, August 6, 2014 ª2014 Elsevier Inc. 583
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NT-3 and Neural Stem CellsTaqman probes were used (Table S2B) and reactions were performed in a
Step One Plus cycler with Taqman Fast Advanced Master Mix (Applied
Biosystems).
Statistical Analysis
All statistical tests were performed using SPSS software (version 13.0; SPSS).
The significance of the differences between groups was evaluated in all exper-
iments by a one-way ANOVA followed by a Tukey post-hoc test. For behavioral
studies, a two-way ANOVA was run followed by Tukey or Bonferroni post-hoc
test. When comparisons were performed with relative values (normalized
values and percentages), data were first normalized using an arcsen transfor-
mation. Values of p < 0.05 were considered statistically significant. Data are
always presented as the mean ± SEM, and the number of experiments per-
formed with independent cultures/animals (n) is indicated.
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